web analytics

Karo Pharma completes the acquisition of Trimb and carries out management changes

Karo Pharma Aktiebolag (”Karo Pharma”) today announces that the acquisition of all the shares of Trimb Holding AB (“Trimb”) from Avista Capital Partners and other shareholders for MSEK 3,400, which was signed on 21 June, 2019 and approved by relevant competition authorities on 4 September, 2019, has been completed. The acquisition of Trimb is expected to contribute positively to Karo Pharma’s market position and create a strong platform for Karo Pharma’s continued growth. Furthermore, the acquisition is expected to bring synergy potential for Karo Pharma in the form of both sales and cost

Source: Karo Pharma completes the acquisition of Trimb and carries out management changes

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.